# A Study of LUMIGAN® RC in the Clinical Setting

> **NCT01833741** · PHASE4 · COMPLETED · sponsor: **Allergan** · enrollment: 1137 (actual)

## Conditions studied

- Glaucoma, Primary Open Angle
- Ocular Hypertension

## Interventions

- **DRUG:** Bimatoprost 0.01%

## Key facts

- **NCT ID:** NCT01833741
- **Lead sponsor:** Allergan
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-12
- **Primary completion:** 2011-03
- **Final completion:** 2011-03
- **Target enrollment:** 1137 (ACTUAL)
- **Last updated:** 2013-09-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01833741

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01833741, "A Study of LUMIGAN® RC in the Clinical Setting". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT01833741. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*